Bernstein on Pfizer's (PFE) FY2025 Guide: 'Nothing Too Surprising, But First Guide on Part D IRA Impact'
Tweet Send to a Friend
Bernstein SocGen Group analyst Courtney Breen reiterated a Market Perform rating and $32.00 price target on Pfizer (NYSE: PFE).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
